Skybiotech Healthcare Limited (BOM:512036)
157.75
+2.55 (1.64%)
At close: Jun 3, 2026
Skybiotech Healthcare Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | -5.94 | -2.69 | 84.33 | 0.17 | 0.12 |
Cash & Short-Term Investments | -5.94 | -2.69 | 84.33 | 0.17 | 0.12 |
Cash Growth | - | - | 48132.08% | 49.45% | -33.85% |
Accounts Receivable | 11.08 | 4.25 | 0 | - | - |
Receivables | 11.19 | 4.25 | 0 | - | - |
Inventory | 8.01 | 15.94 | - | - | - |
Prepaid Expenses | - | 0.01 | - | - | - |
Other Current Assets | -0 | 1.67 | 1.63 | 0.03 | 0.04 |
Total Current Assets | 13.25 | 19.18 | 85.96 | 0.21 | 0.16 |
Property, Plant & Equipment | 83.73 | 88.44 | 0.05 | 0.06 | 0.07 |
Long-Term Investments | 22.43 | 24.65 | 25.87 | 36.97 | 40.1 |
Goodwill | 31.31 | 31.31 | - | - | - |
Other Intangible Assets | 0.45 | 0.52 | - | - | - |
Long-Term Deferred Tax Assets | 15.28 | 9.23 | - | - | - |
Other Long-Term Assets | 3.04 | 27.67 | 3.38 | 3.38 | 3.38 |
Total Assets | 194.41 | 200.98 | 115.26 | 40.62 | 43.71 |
Accounts Payable | 8.5 | 6.23 | - | - | - |
Accrued Expenses | - | 2.07 | 0.2 | 0.04 | 0.06 |
Short-Term Debt | 1.67 | 1.9 | - | - | - |
Current Income Taxes Payable | - | 0.16 | 3.39 | - | - |
Other Current Liabilities | 9.23 | 15.16 | 0.44 | - | - |
Total Current Liabilities | 19.39 | 25.53 | 4.07 | 0.07 | 0.08 |
Long-Term Debt | 82.49 | 70.08 | - | - | - |
Long-Term Deferred Tax Liabilities | - | - | 2.87 | 5.65 | 6.43 |
Other Long-Term Liabilities | 0 | -0 | 0 | - | - |
Total Liabilities | 101.88 | 95.61 | 6.94 | 5.72 | 6.52 |
Common Stock | 19.15 | 19.15 | 19.15 | 10.4 | 10.4 |
Additional Paid-In Capital | - | - | 58.04 | 5.54 | 5.54 |
Retained Earnings | - | - | 15.85 | 0.5 | 0.57 |
Comprehensive Income & Other | 60.79 | 70.72 | 15.28 | 18.46 | 20.68 |
Total Common Equity | 79.94 | 89.87 | 108.32 | 34.9 | 37.2 |
Minority Interest | 12.59 | 15.5 | - | - | - |
Shareholders' Equity | 92.53 | 105.37 | 108.32 | 34.9 | 37.2 |
Total Liabilities & Equity | 194.41 | 200.98 | 115.26 | 40.62 | 43.71 |
Total Debt | 84.15 | 71.98 | - | - | - |
Net Cash (Debt) | -90.1 | -74.67 | 84.33 | 0.17 | 0.12 |
Net Cash Growth | - | - | 48132.08% | 49.45% | -33.85% |
Net Cash Per Share | -54.05 | -38.99 | 44.04 | 0.17 | 0.11 |
Filing Date Shares Outstanding | - | 1.92 | 1.92 | 1.04 | 1.04 |
Total Common Shares Outstanding | - | 1.92 | 1.92 | 1.04 | 1.04 |
Working Capital | -6.14 | -6.35 | 81.89 | 0.13 | 0.08 |
Book Value Per Share | - | 46.93 | 56.56 | 33.55 | 35.76 |
Tangible Book Value | 48.18 | 58.05 | 108.32 | 34.9 | 37.2 |
Tangible Book Value Per Share | - | 30.31 | 56.56 | 33.55 | 35.76 |
Land | - | 25.31 | - | - | - |
Buildings | - | 85.14 | - | - | - |
Machinery | - | 68.16 | 0.52 | 0.52 | 0.52 |